New Key Statistics Module, Z-Score and F-Score
NAS:REGN Key Ratios
Market Cap $ M | 105,340.69 |
Enterprise Value $ M | 97,798.09 |
P/E(ttm) | 27.62 |
PE Ratio without NRI | 23.93 |
Forward PE Ratio | 21.33 |
Price/Book | 4.04 |
Price/Sales | 8.33 |
Price/Free Cash Flow | 29.75 |
Price/Owner Earnings | 39.69 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 13,117.00 |
EPS (TTM) $ | 34.75 |
Beneish M-Score | -2.51 |
10-y EBITDA Growth Rate % | 24.90 |
5-y EBITDA Growth Rate % | 17.70 |
y-y EBITDA Growth Rate % | -10.90 |
EV-to-EBIT | 22.89 |
EV-to-EBITDA | 20.84 |
PEG | 1.35 |
Shares Outstanding M | 109.76 |
Net Margin (%) | 30.14 |
Operating Margin % | 32.27 |
Pre-tax Margin (%) | 32.01 |
Quick Ratio | 4.94 |
Current Ratio | 5.69 |
ROA % (ttm) | 12.74 |
ROE % (ttm) | 16.33 |
ROIC % (ttm) | 21.07 |
Dividend Yield % | -- |
Altman Z-Score | 11.50 |
Piotroski F-Score | 6.00 |
Positive ROA | Y |
Positive CFROA | Y |
Higher ROA y-y | N |
Cash flow > Earnings | Y |
Lower Leverage y-y | Y |
Higher Current Ratio y-y | Y |
Less Shares Outstanding y-y | Y |
Gross Margin Increase y-y | N |
Higher Asset Turnover y-y | N |
REGN Number of Guru Trades
REGN Volume of Guru Trades
Gurus Latest Trades with NAS:REGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:REGN is held by these investors
Total 6
Regeneron Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:REGN
Total 0- 1